UAB "Biofarmacija" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 5,395,967 |
| 234,098 |
| 342,089 |
| 320,600 |
| 13,909 |
| 45.72 |
| 5.94 |
| 3,792,048 |
| 2,122,570 |
| 2,276,741 |
| 3,637,877 |
| 2023 |
|---|
| 6,430,016 |
| 290,294 |
| 895,932 |
| 684,842 |
| 30,918 |
| 51.64 |
| 10.65 |
| 4,476,890 |
| 2,011,953 |
| 2,498,821 |
| 3,988,391 |
| 2024 |
|---|
| 7,653,714 |
| 424,734 |
| 950,188 |
| 813,492 |
| 45,144 |
| 45.54 |
| 10.63 |
| 5,290,382 |
| 1,229,158 |
| 1,216,169 |
| 5,302,048 |
Register and
explore Okredo data| 2024 |
|---|
| 7,653,714 |
| 424,734 |
| 950,188 |
| 813,492 |
| 45,144 |
| 45.54 |
| 10.63 |
| 5,290,382 |
| 1,229,158 |
| 1,216,169 |
| 5,302,048 |
Register and
explore Okredo data2024
Turnover (€)
7,653,714 €
19 % *
Sales per employee (€)
424,734 €46 % *
Profit before tax (€)
950,188 €6 % *
Net Profit (€)
813,492 €19 % *
Profit per employee (€)
45,144 €46 % *
Total profitability (%)
45.54 %
-11.81 % *
Net profitability (%)
10.63 %-0.19 % *
Equity (€)
5,290,382 €18 % *
Amounts Payable And Liabilities (€)
1,229,158 €
-39 % *
Non-current Assets (€)
1,216,169 €-51 % *
CurrentAssets (€)
5,302,048 €
33 % *